๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Current status of adjuvant systemic therapy for primary breast cancer: Progress and controversy

โœ Scribed by Gabriel N. Hortobagyi; Aman U. Buzdar

Book ID
115069617
Publisher
American Cancer Society
Year
1995
Tongue
English
Weight
158 KB
Volume
45
Category
Article
ISSN
0007-9235

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Current and future status of adjuvant th
Current and future status of adjuvant therapy for breast cancer
โœ Robert E. Coleman ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 2 views

Adjuvant systemic treatments have greatly improved the prognosis of women with early breast cancer. Combination chemotherapy and, for patients with oestrogen receptor-positive (ER+) tumours, endocrine treatment has been found to reduce the frequency of relapse and improve survival. New adjuvant stra

Systemic adjuvant therapy of breast canc
Systemic adjuvant therapy of breast cancer
โœ Garrett, Thomas J.; Vahdat, Linda T.; Kinne, David W. ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 52 KB ๐Ÿ‘ 2 views

Systematic adjuvant therapy has improved the outcome for women with operable breast cancer. As a result, a substantial proportion of patients with this disease are candidates for adjuvant treatment. In providing a woman with recommendations for therapy, her risk of developing recurrent breast cancer

Adjuvant systemic therapy for early brea
Adjuvant systemic therapy for early breast cancer
โœ John Crown; Larry Norton ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 890 KB

Sytemic therapy (chemotherapy or hormonal therapy) as an adjuvant to modalities of local control is now an integral part of the management of almost all patients with primary breast cancer metastatic to axillary lymph nodes. In addition, recent data suggest an expanding role for such treatments in p